Analyses of costs and financing of the routine immunization program and new vaccine introduction in the Republic of Moldova
The costs and financing of the national immunization programs have been evaluated since 1980s, particularly as part of Universal Childhood Immunization Initiative. However, available information is out-dated and up-to-date knowledge on full economic costs and financing of routine immunization programs, as well as the financial cost and financing of a new vaccine introduction is lacking. For going forward and increasing vaccine coverage rates as well as for introduction of new vaccines in national immunization programs, requires better knowledge of costs as well as cost determinants. Therefore, the purpose of this study is to evaluate routine immunization program costs and financing as well as incremental costs and financing of a new vaccine introduction in the Republic of Moldova. Our study is part of a larger effort to evaluate costs and financing of routine immunization in six countries (Moldova, Benin, Uganda, Zambia, Ghana, Honduras) supported by the Bill & Melinda Gates Foundation.
|Country||Republic Of Moldova|
|Disease||, Diphtheria , Pertussis , Pneumococcal disease , Rotavirus , Tetanus , Tuberculosis|
|Added on||4 November 2016 13:58:55|
Add to Favourites